ArticleEuropean journal of nuclear medicine and molecular imaging2012

Predictive value of pretreatment metabolic activity measured by fluorodeoxyglucose positron emission tomography in patients with metastatic advanced gastric cancer: the maximal SUV of the stomach is a prognostic factor.

Jun Chul Park et al.PubMed ↗Publisher ↗

No numbers read from the abstract.